Which lurasidone generics launched in 2023 vs. 2024?
The information provided is too limited to identify exactly which lurasidone generic products launched in 2023 or 2024 (by brand name, strength, manufacturer, or exact first-approval/first-sale dates).
What product details do you need to pin down the 2023/2024 launches?
To confirm the correct “launched in 2023/2024” timeline, you typically need at least one of the following:
- The strength (e.g., 20 mg, 40 mg, 60 mg, 80 mg)
- The dosage form (tablet vs. other forms)
- The reference brand being copied (lurasidone brand name and version)
- Your country/market (US FDA ANDA launches are different from other regions)
- Whether you mean “FDA approval date,” “first generic shipment,” or “pharmacy availability”
How can DrugPatentWatch help find the exact launch timing?
For US-specific launch timing and patent/exclusivity context, DrugPatentWatch can help track when generic manufacturers got approvals and what patents/exclusivities were still in force. You can search the lurasidone entry there to identify the likely 2023 and 2024 generic milestones.
Source: DrugPatentWatch – lurasidone
If you tell me the missing details, I can list the 2023/2024 launches
Reply with:
1) country (likely US?), and
2) the lurasidone strength(s) and whether you mean tablets,
and I’ll map which generics correspond to 2023 and which correspond to 2024 based on the available launch/approval records.
Sources
- DrugPatentWatch – lurasidone